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Abstract
Background: A major bottleneck in our understanding of the molecular underpinnings of life is the assignment of
function to proteins. While molecular experiments provide the most reliable annotation of proteins, their relatively
low throughput and restricted purview have led to an increasing role for computational function prediction. However,
assessing methods for protein function prediction and tracking progress in the field remain challenging.
Results: We conducted the second critical assessment of functional annotation (CAFA), a timed challenge to assess
computational methods that automatically assign protein function. We evaluated 126 methods from 56 research
groups for their ability to predict biological functions using Gene Ontology and gene-disease associations using
Human Phenotype Ontology on a set of 3681 proteins from 18 species. CAFA2 featured expanded analysis compared
with CAFA1, with regards to data set size, variety, and assessment metrics. To review progress in the field, the analysis
compared the best methods from CAFA1 to those of CAFA2.
Conclusions: The top-performing methods in CAFA2 outperformed those from CAFA1. This increased accuracy
can be attributed to a combination of the growing number of experimental annotations and improved methods
for function prediction. The assessment also revealed that the definition of top-performing algorithms is ontology
specific, that different performance metrics can be used to probe the nature of accurate predictions, and the relative
diversity of predictions in the biological process and human phenotype ontologies. While there was methodological
improvement between CAFA1 and CAFA2, the interpretation of results and usefulness of individual methods remain
context-dependent.
Keywords: Protein function prediction, Disease gene prioritization
Background
Accurate computer-generated functional annotations of
biological macromolecules allow biologists to rapidly gen-
erate testable hypotheses about the roles that newly
identified proteins play in processes or pathways. They
also allow them to reason about new species based
on the observed functional repertoire associated with
their genes. However, protein function prediction is an
open research problem and it is not yet clear which
tools are best for predicting function. At the same time,
critically evaluating these tools and understanding the
landscape of the function prediction field is a chal-
lenging task that extends beyond the capabilities of a
single lab.
Assessments and challenges have a successful history
of driving the development of new methods in the life
sciences by independently assessing performance and
providing discussion forums for the researchers [1]. In
2010–2011, we organized the first critical assessment
of functional annotation (CAFA) challenge to evaluate
methods for the automated annotation of protein func-
tion and to assess the progress in method develop-
ment in the first decade of the 2000s [2]. The challenge
used a time-delayed evaluation of predictions for a large
set of target proteins without any experimental func-
tional annotation. A subset of these target proteins accu-
mulated experimental annotations after the predictions
were submitted and was used to estimate the perfor-
mance accuracy. The estimated performance was subse-
quently used to draw conclusions about the status of the
field.
The first CAFA (CAFA1) showed that advanced meth-
ods for the prediction of Gene Ontology (GO) terms
[3] significantly outperformed a straightforward applica-
tion of function transfer by local sequence similarity. In
addition to validating investment in the development of
new methods, CAFA1 also showed that using machine
learning to integrate multiple sequence hits and multi-
ple data types tends to perform well. However, CAFA1
also identified challenges for experimentalists, biocu-
rators, and computational biologists. These challenges
include the choice of experimental techniques and pro-
teins in functional studies and curation, the structure
and status of biomedical ontologies, the lack of com-
prehensive systems data that are necessary for accurate
prediction of complex biological concepts, as well as
limitations of evaluation metrics [2, 4–7]. Overall, by
establishing the state-of-the-art in the field and identi-
fying challenges, CAFA1 set the stage for quantifying
progress in the field of protein function prediction over
time.
In this study, we report on the major outcomes of
the second CAFA experiment, CAFA2, that was orga-
nized and conducted in 2013–2014, exactly 3 years after
the original experiment. We were motivated to evalu-
ate the progress in method development for function
prediction as well as to expand the experiment to new
ontologies. The CAFA2 experiment also greatly expanded
the performance analysis to new types of evaluation and
included new performance metrics. By surveying the state
of the field, we aim to help all direct and indirect users
of computational function prediction software develop
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intuition for the quality, robustness, and reliability of these
predictions.
Methods
Experiment overview
The time line for the second CAFA experiment followed
that of the first experiment and is illustrated in Fig. 1.
Briefly, CAFA2 was announced in July 2013 and officially
started in September 2013, when 100,816 target sequences
from 27 species were made available to the community.
Teams were required to submit prediction scores within
the (0, 1] range for each protein–term pair they chose
to predict on. The submission deadline for depositing
these predictions was set for January 2014 (time point t0).
We then waited until September 2014 (time point t1) for
new experimental annotations to accumulate on the target
proteins and assessed the performance of the prediction
methods. We will refer to the set of all experimentally
annotated proteins available at t0 as the training set and
to a subset of target proteins that accumulated experi-
mental annotations during (t0, t1] and used for evaluation
as the benchmark set. It is important to note that the
benchmark proteins and the resulting analysis vary based
on the selection of time point t1. For example, a pre-
liminary analysis of the CAFA2 experiment was provided
during the Automated Function Prediction Special Inter-
est Group (AFP-SIG) meeting at the Intelligent Systems
for Molecular Biology (ISMB) conference in July 2014.
The participating methods were evaluated according
to their ability to predict terms in GO [3] and Human
Phenotype Ontology (HPO) [8]. In contrast with CAFA1,
where the evaluation was carried out only for the Molec-
ular Function Ontology (MFO) and Biological Process
Ontology (BPO), in CAFA2 we also assessed the perfor-
mance for the prediction of Cellular ComponentOntology
(CCO) terms in GO. The set of human proteins was fur-
ther used to evaluate methods according to their ability
to associate these proteins with disease terms from HPO,
which included all sub-classes of the term HP:0000118,
“Phenotypic abnormality”.
In total, 56 groups submitting 126 methods participated
in CAFA2. From those, 125 methods made valid predic-
tions on a sufficient number of sequences. Further, 121
methods submitted predictions for at least one of the GO
benchmarks, while 30 methods participated in the disease
gene prediction tasks using HPO.
Evaluation
The CAFA2 experiment expanded the assessment of com-
putational function prediction compared with CAFA1.
This includes the increased number of targets, bench-
marks, ontologies, and method comparison metrics.
We distinguish between two major types of method
evaluation. The first, protein-centric evaluation, assesses
performance accuracy of methods that predict all onto-
logical terms associated with a given protein sequence.
The second type, term-centric evaluation, assesses per-
formance accuracy of methods that predict if a single
ontology term of interest is associated with a given pro-
tein sequence [2]. The protein-centric evaluation can be
viewed as a multi-label or structured-output learning
problem of predicting a set of terms or a directed acyclic
graph (a subgraph of the ontology) for a given protein.
Because the ontologies contain many terms, the output
space in this setting is extremely large and the evaluation
metrics must incorporate similarity functions between
groups of mutually interdependent terms (directed acyclic
graphs). In contrast, the term-centric evaluation is an
example of binary classification, where a given ontology
term is assigned (or not) to an input protein sequence.
These methods are particularly common in disease gene
prioritization [9]. Put otherwise, a protein-centric evalu-
ation considers a ranking of ontology terms for a given
protein, whereas the term-centric evaluation considers
a ranking of protein sequences for a given ontology
term.
Both types of evaluation have merits in assessing per-
formance. This is partly due to the statistical depen-
dency between ontology terms, the statistical dependency
among protein sequences, and also the incomplete and
Fig. 1 Time line for the CAFA2 experiment
Jiang et al. Genome Biology  (2016) 17:184 Page 4 of 19
biased nature of the experimental annotation of protein
function [6]. In CAFA2, we provide both types of evalu-
ation, but we emphasize the protein-centric scenario for
easier comparisons with CAFA1. We also draw important
conclusions regarding method assessment in these two
scenarios.
No-knowledge and limited-knowledge benchmark sets
In CAFA1, a protein was eligible to be in the bench-
mark set if it had not had any experimentally veri-
fied annotations in any of the GO ontologies at time
t0 but accumulated at least one functional term with
an experimental evidence code between t0 and t1;
we refer to such benchmark proteins as no-knowledge
benchmarks. In CAFA2 we introduced proteins with
limited knowledge, which are those that had been exper-
imentally annotated in one or two GO ontologies (but
not in all three) at time t0. For example, for the per-
formance evaluation in MFO, a protein without any
annotation in MFO prior to the submission deadline
was allowed to have experimental annotations in BPO
and CCO.
During the growth phase, the no-knowledge targets that
have acquired experimental annotations in one or more
ontologies became benchmarks in those ontologies. The
limited-knowledge targets that have acquired additional
annotations became benchmarks only for those ontologies
for which there were no prior experimental annotations.
The reason for using limited-knowledge targets was to
identify whether the correlations between experimental
annotations across ontologies can be exploited to improve
function prediction.
The selection of benchmark proteins for evaluating
HPO-term predictors was separated from the GO analy-
ses.We created only a no-knowledge benchmark set in the
HPO category.
Partial and full evaluationmodes
Many function prediction methods apply only to certain
types of proteins, such as proteins for which 3D structure
data are available, proteins from certain taxa, or specific
subcellular localizations. To accommodate thesemethods,
CAFA2 provided predictors with an option of choosing a
subset of the targets to predict on as long as they com-
putationally annotated at least 5,000 targets, of which
at least ten accumulated experimental terms. We refer
to the assessment mode in which the predictions were
evaluated only on those benchmarks for which a model
made at least one prediction at any threshold as partial
evaluation mode. In contrast, the full evaluation mode
corresponds to the same type of assessment performed in
CAFA1 where all benchmark proteins were used for the
evaluation and methods were penalized for not making
predictions.
In most cases, for each benchmark category, we have
two types of benchmarks, no-knowledge and limited-
knowledge, and two modes of evaluation, full mode
and partial mode. Exceptions are all HPO categories
that only have no-knowledge benchmarks. The full
mode is appropriate for comparisons of general-purpose
methods designed to make predictions on any pro-
tein, while the partial mode gives an idea of how
well each method performs on a self-selected subset of
targets.
Evaluationmetrics
Precision–recall curves and remaining uncertainty–
misinformation curves were used as the two chief metrics
in the protein-centric mode [10]. We also provide a sin-
gle measure for evaluation of both types of curves as a
real-valued scalar to compare methods; however, we note
that any choice of a single point on those curves may
not match the intended application objectives for a given
algorithm. Thus, a careful understanding of the evaluation
metrics used in CAFA is necessary to properly interpret
the results.
Precision (pr), recall (rc), and the resulting Fmax are
defined as
pr(τ ) = 1m(τ )
m(τ )∑
i=1
∑
f 1
(
f ∈ Pi(τ ) ∧ f ∈ Ti
)
∑
f 1
(
f ∈ Pi(τ )
) ,
rc(τ ) = 1ne
ne∑
i=1
∑
f 1
(
f ∈ Pi(τ ) ∧ f ∈ Ti
)
∑
f 1
(
f ∈ Ti
) ,
Fmax = max
τ
{2 · pr(τ ) · rc(τ )
pr(τ ) + rc(τ )
}
,
where Pi(τ ) denotes the set of terms that have predicted
scores greater than or equal to τ for a protein sequence
i, Ti denotes the corresponding ground-truth set of terms
for that sequence, m(τ ) is the number of sequences with
at least one predicted score greater than or equal to τ , 1 (·)
is an indicator function, and ne is the number of targets
used in a particular mode of evaluation. In the full evalu-
ation mode ne = n, the number of benchmark proteins,
whereas in the partial evaluation mode ne = m(0), i.e.,
the number of proteins that were chosen to be predicted
using the particular method. For each method, we refer
to m(0)/n as the coverage because it provides the fraction
of benchmark proteins on which the method made any
predictions.
The remaining uncertainty (ru), misinformation (mi),
and the resulting minimum semantic distance (Smin) are
defined as
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ru(τ ) = 1ne
ne∑
i=1
∑
f
ic(f ) · 1 (f /∈ Pi(τ ) ∧ f ∈ Ti) ,
mi(τ ) = 1ne
ne∑
i=1
∑
f
ic(f ) · 1 (f ∈ Pi(τ ) ∧ f /∈ Ti) ,
Smin = min
τ
{√
ru(τ )2 + mi(τ )2
}
,
where ic(f ) is the information content of the ontology
term f [10]. It is estimated in a maximum likelihood
manner as the negative binary logarithm of the condi-
tional probability that the term f is present in a protein’s
annotation given that all its parent terms are also present.
Note that here, ne = n in the full evaluation mode and
ne = m(0) in the partial evaluation mode applies to both
ru and mi.
In addition to the main metrics, we used two sec-
ondary metrics. Those were the weighted version of the
precision–recall curves and the version of the remain-
ing uncertainty–misinformation curves normalized to the
[0, 1] interval. These metrics and the corresponding eval-
uation results are shown in Additional file 1.
For the term-centric evaluation we used the area under
the receiver operating characteristic (ROC) curve (AUC).
The AUCs were calculated for all terms that have acquired
at least ten positively annotated sequences, whereas the
remaining benchmarks were used as negatives. The term-
centric evaluation was used both for ranking models and
to differentiate well and poorly predictable terms. The
performance of each model on each term is provided in
Additional file 1.
As we required all methods to keep two significant
figures for prediction scores, the threshold τ in all metrics
used in this study was varied from 0.01 to 1.00 with a step
size of 0.01.
Data sets
Protein function annotations for the GO assessment were
extracted, as a union, from three major protein databases
that are available in the public domain: Swiss-Prot [11],
UniProt-GOA [12] and the data from the GO consor-
tium web site [3]. We used evidence codes EXP, IDA,
IPI, IMP, IGI, IEP, TAS, and IC to build benchmark and
ground-truth sets. Annotations for the HPO assessment
were downloaded from the HPO database [8].
Figure 2 summarizes the benchmarks we used in this
study. Figure 2a shows the benchmark sizes for each of
the ontologies and compares these numbers to CAFA1.
All species that have at least 15 proteins in any of the
benchmark categories are listed in Fig. 2b.
Comparison between CAFA1 and CAFA2methods
We compared the results from CAFA1 and CAFA2 using
a benchmark set that we created from CAFA1 targets and
CAFA2 targets. More precisely, we used the stored pre-
dictions of the target proteins from CAFA1 and compared
them with the new predictions from CAFA2 on the over-
lapping set of CAFA2 benchmarks and CAFA1 targets
Fig. 2 CAFA2 benchmark breakdown. a The benchmark size for each of the four ontologies. b Breakdown of benchmarks for both types over 11
species (with no less than 15 proteins) sorted according to the total number of benchmark proteins. For both panels, dark colors (blue, red, and
yellow) correspond to no-knowledge (NK) types, while their light color counterparts correspond to limited-knowledge (LK) types. The distributions of
information contents corresponding to the benchmark sets are shown in Additional file 1. The size of CAFA 1 benchmarks are shown in gray. BPO
Biological Process Ontology, CCO Cellular Component Ontology, HPO Human Phenotype Ontology, LK limited-knowledge,MFOMolecular Function
Ontology, NK no-knowledge
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(a sequence had to be a no-knowledge target in both
experiments to be eligible for this evaluation). For this
analysis only, we used an artificial GO version by taking
the intersection of the two GO snapshots (versions from
January 2011 and June 2013) so as to mitigate the influ-
ence of ontology changes. We, thus, collected 357 bench-
mark proteins for MFO comparisons and 699 for BPO
comparisons. The two baseline methods were trained on
respective Swiss-Prot annotations for both ontologies so
that they serve as controls for database change. In par-
ticular, SwissProt2011 (for CAFA1) contained 29,330 and
31,282 proteins for MFO and BPO, while SwissProt2014
(for CAFA2) contained 26,907 and 41,959 proteins for the
two ontologies.
To conduct a head-to-head analysis between any two
methods, we generated B = 10, 000 bootstrap samples
and let methods compete on each such benchmark set.
The performance improvement δ from CAFA1 to CAFA2
was calculated as
δ(m2,m1) = 1B
B∑
b=1
F(b)max(m2) −
1
B
B∑
b=1
F(b)max(m1),
where m1 and m2 stand for methods from CAFA1 and
CAFA2, respectively, and F(b)max(·) represents the Fmax of
a method evaluated on the b-th bootstrapped benchmark
set.
Baseline models
We built two baseline methods, Naïve and BLAST, and
compared them with all participating methods. The Naïve
method simply predicts the frequency of a term being
annotated in a database [13]. BLAST was based on search
results using the Basic Local Alignment Search Tool
(BLAST) software against the training database [14]. A
term will be predicted as the highest local alignment
sequence identity among all BLAST hits annotated with
the term. Both of these methods were trained on the
experimentally annotated proteins available in Swiss-Prot
at time t0, except for HPO where the two baseline models
were trained using the annotations from the t0 release of
the HPO.
Results and discussion
Topmethods have improved since CAFA1
We conducted the second CAFA experiment 3 years after
the first one. As our knowledge of protein function has
increased since then, it was worthwhile to assess whether
computational methods have also been improved and if
so, to what extent. Therefore, to monitor the progress over
time, we revisit some of the top methods in CAFA1 and
compare them with their successors.
For each benchmark set we carried out a bootstrap-
based comparison between a pair of top-ranked methods
(one fromCAFA1 and another fromCAFA2), as described
in “Methods”. The average performance metric as well as
the number of wins were recorded (in the case of iden-
tical performance, neither method was awarded a win).
Figure 3 summarizes the results of this analysis. We use
a color code from orange to blue to indicate the perfor-
mance improvement δ from CAFA1 to CAFA2.
The selection of top methods for this study was based
on their performance in each ontology on the entire
benchmark sets. Panels B and C in Fig. 3 compare base-
line methods trained on different data sets. We see no
improvements of these baselines except for BLAST on
BPO where it is slightly better to use the newer version
of Swiss-Prot as the reference database for the search.
On the other hand, all top methods in CAFA2 out-
performed their counterparts in CAFA1. For predicting
molecular functions, even though transferring functions
from BLAST hits does not give better results, the top
models still managed to perform better. It is possible that
the newly acquired annotations since CAFA1 enhanced
BLAST, which involves direct function transfer, and per-
haps lead to better performances of those downstream
methods that rely on sequence alignments. However, this
effect does not completely explain the extent of the per-
formance improvement achieved by those methods. This
is promising evidence that top methods from the commu-
nity have improved since CAFA1 and that improvements
were not simply due to updates of curated databases.
Protein-centric evaluation
Protein-centric evaluation measures how accurately
methods can assign functional terms to a protein. The
protein-centric performance evaluation of the top-ten
methods is shown in Figs. 4, 5, and 6. The 95 % con-
fidence intervals were estimated using bootstrapping on
the benchmark set with B = 10, 000 iterations [15]. The
results provide a broad insight into the state of the art.
Predictors performed very differently across the four
ontologies. Various reasons contribute to this effect
including: (1) the topological properties of the ontology
such as the size, depth, and branching factor; (2) term pre-
dictability; for example, the BPO terms are considered to
be more abstract in nature than theMFO and CCO terms;
(3) the annotation status, such as the size of the training
set at t0, the annotation depth of benchmark proteins, as
well as various annotation biases [6].
In general, CAFA2 methods perform better at pre-
dicting MFO terms than any other ontology. Top meth-
ods achieved Fmax scores around 0.6 and considerably
surpassed the two baseline models. Maintaining the
pattern from CAFA1, the performance accuracies in
the BPO category were not as good as in the MFO
category. The best-performing method scored slightly
below 0.4.
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Fig. 3 CAFA1 versus CAFA2 (topmethods). A comparison in Fmax between the top-five CAFA1 models against the top-five CAFA2 models. Colored
boxes encode the results such that (1) the colors indicate margins of a CAFA2 method over a CAFA1 method in Fmax and (2) the numbers in the box
indicate the percentage of wins. For both the Molecular Function Ontology (a) and Biological Process Ontology (b) results: A CAFA1 top-five models
(rows, from top to bottom) against CAFA2 top-five models (columns, from left to right). B Comparison of Naïve baselines trained respectively on
SwissProt2011 and SwissProt2014. C Comparison of BLAST baselines trained on SwissProt2011 and SwissProt2014
For the two newly added ontologies in CAFA2, we
observed that the top predictors performed no better
than the Naïve method under Fmax, whereas they slightly
outperformed the Naïve method under Smin in CCO.
One reason for the competitive performance of the Naïve
method in the CCO category is that a small number of
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Fig. 4 Overall evaluation using the maximum F measure, Fmax. Evaluation was carried out on no-knowledge benchmark sequences in the full mode.
The coverage of each method is shown within its performance bar. A perfect predictor would be characterized with Fmax = 1. Confidence intervals
(95 %) were determined using bootstrapping with 10,000 iterations on the set of benchmark sequences. For cases in which a principal investigator
participated in multiple teams, the results of only the best-scoring method are presented. Details for all methods are provided in Additional file 1
relatively general terms are frequently used, and those rel-
ative frequencies do not diffuse quickly enough with the
depth of the graph. For instance, the annotation frequency
of “organelle” (GO:0043226, level 2), “intracellular part”
(GO:0044424, level 3), and “cytoplasm” (GO:0005737,
level 4) are all above the best threshold for the Naïve
method (τoptimal = 0.32). Correctly predicting these
terms increases the number of true positives and thus
boosts the performance of the Naïve method under the
Fmax evaluation. However, once the less informative terms
are down-weighted (using the Smin measure), the Naïve
method becomes significantly penalized and degraded.
Another reason for the comparatively good performance
of Naïve is that the benchmark proteins were annotated
with more general terms than the (training) proteins pre-
viously deposited in the UniProt database. This effect was
most prominent in the CCO (Additional file 1: Figure S2)
and has thus artificially boosted the performance of the
Naïve method. The weighted Fmax and normalized Smin
evaluations can be found in Additional file 1.
Interestingly, generally shallower annotations of bench-
mark proteins do not seem to be the major reason for the
observed performance in the HPO category. One possi-
bility for the observed performance is that, unlike for GO
terms, the HPO annotations are difficult to transfer from
other species. Another possibility is the sparsity of exper-
imental annotations. The current number of experimen-
tally annotated proteins in HPO is 4794, i.e., 0.5 proteins
per HPO term, which is at least an order of magnitude less
than for other ontologies. Finally, the relatively high fre-
quency of general terms may have also contributed to the
good performance of Naïve. We originally hypothesized
that a possible additional explanation for this effect might
be that the average number of HPO terms associated with
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Fig. 5 Precision–recall curves for top-performing methods. Evaluation was carried out on no-knowledge benchmark sequences in the full mode.
A perfect predictor would be characterized with Fmax = 1, which corresponds to the point (1, 1) in the precision–recall plane. For cases in which a
principal investigator participated in multiple teams, the results of only the best-scoring method are presented
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Fig. 6 Overall evaluation using the minimum semantic distance, Smin. Evaluation was carried out on no-knowledge benchmark sequences in the full
mode. The coverage of each method is shown within its performance bar. A perfect predictor would be characterized with Smin = 0. Confidence
intervals (95 %) were determined using bootstrapping with 10,000 iterations on the set of benchmark sequences. For cases in which a principal
investigator participated in multiple teams, the results of only the best-scoring method are presented. Details for all methods are provided in
Additional file 1
a human protein is considerably larger than in GO; i.e.,
the mean number of annotations per protein in HPO is
84, while for MFO, BPO, and CCO, the mean number
of annotations per protein is 10, 39, and 14, respectively.
However, we do not observe this effect in other ontolo-
gies when the benchmark proteins are split into those with
a low or high number of terms. Overall, successfully pre-
dicting the HPO terms in the protein-centric mode is a
difficult problem and further effort will be required to
fully characterize the performance.
Term-centric evaluation
The protein-centric view, despite its power in showing
the strengths of a predictor, does not gauge a predic-
tor’s performance for a specific function. In a term-centric
evaluation, we assess the ability of eachmethod to identify
new proteins that have a particular function, participate
in a process, are localized to a component, or affect a
human phenotype. To assess this term-wise accuracy, we
calculated AUCs in the prediction of individual terms.
Averaging the AUC values over terms provides a metric
for ranking predictors, whereas averaging predictor per-
formance over terms provides insights into how well this
term can be predicted computationally by the community.
Figure 7 shows the performance evaluation where the
AUCs for each method were averaged over all terms
for which at least ten positive sequences were available.
Proteins without predictions were counted as predictions
with a score of 0. As shown in Figs. 4, 5, and 6, correctly
predicting CCO and HPO terms for a protein might not
be an easy task according to the protein-centric results.
However, the overall poor performance could also result
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Fig. 7 Overall evaluation using the averaged AUC over terms with no less than ten positive annotations. The evaluation was carried out on
no-knowledge benchmark sequences in the full mode. Error bars indicate the standard error in averaging AUC over terms for each method. For
cases in which a principal investigator participated in multiple teams, the results of only the best-scoring method are presented. Details for all
methods are provided in Additional file 1. AUC receiver operating characteristic curve
from the dominance of poorly predictable terms. There-
fore, a term-centric view can help differentiate prediction
quality across terms. As shown in Fig. 8, most of the
terms in HPO obtain an AUC greater than the Naïve
model, with some terms on average achieving reason-
ably well AUCs around 0.7. Depending on the training
data available for participating methods, well-predicted
phenotype terms range frommildly specific such as “Lym-
phadenopathy” and “Thrombophlebitis” to general ones
such as “Abnormality of the Skin Physiology”.
Performance on various categories of benchmarks
Easy versus difficult benchmarks
As in CAFA1, the no-knowledge GO benchmarks were
divided into easy versus difficult categories based on their
maximal global sequence identity with proteins in the
training set. Since the distribution of sequence identi-
ties roughly forms a bimodal shape (Additional file 1), a
cutoff of 60 % was manually chosen to define the two
categories. The same cutoff was used in CAFA1. Unsur-
prisingly, across all three ontologies, the performance of
the BLASTmodel was substantially impacted for the diffi-
cult category because of the lack of high sequence identity
homologs and as a result, transferring annotations was rel-
atively unreliable. However, we also observed that most
top methods were insensitive to the types of benchmarks,
which provides us with encouraging evidence that state-
of-the-art protein function predictors can successfully
combine multiple potentially unreliable hits, as well as
multiple types of data, into a reliable prediction.
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a b
Fig. 8 Averaged AUC per term for Human Phenotype Ontology. a Terms are sorted based on AUC. The dashed red line indicates the performance of
the Naïve method. b The top-ten accurately predicted terms without overlapping ancestors (except for the root). AUC receiver operating
characteristic curve
Species-specific categories
The benchmark proteins were split into even smaller
categories for each species as long as the resulting cate-
gory contained at least 15 sequences. However, because
of space limitations, in Fig. 9 we show the breakdown
results on only eukarya and prokarya benchmarks; the
species-specific results are provided in Additional file 1.
It is worth noting that the performance accuracies on the
entire benchmark sets were dominated by the targets from
eukarya due to their larger proportion in the benchmark
set and annotation preferences. The eukarya benchmark
rankings therefore coincide with the overall rankings, but
the smaller categories typically showed different rank-
ings and may be informative to more specialized research
groups.
For all three GO ontologies, no-knowledge prokarya
benchmark sequences collected over the annotation
growth phase mostly (over 80 %) came from two species:
Escherichia coli and Pseudomonas aeruginosa (for CCO,
21 out of 22 proteins were from E. coli). Thus, one
should keep in mind that the prokarya benchmarks essen-
tially reflect the performance on proteins from these
two species. Methods predicting the MFO terms for
prokaryotes are slightly worse than those for eukary-
otes. In addition, direct function transfer by homology
for prokaryotes did not work well using this ontology.
However, the performance was better using the other two
ontologies, especially CCO. It is not very surprising that
the top methods achieved good performance for E. coli as
it is a well-studied model organism.
Diversity of predictions
Evaluation of the top methods revealed that perfor-
mance was often statistically indistinguishable between
the best methods. This could result from all top methods
making the same predictions, or from different predic-
tion sets resulting in the same summarized performance.
To assess this, we analyzed the extent to which meth-
ods generated similar predictions within each ontology.
Specifically, we calculated the pairwise Pearson correla-
tion between methods on a common set of gene-concept
pairs and then visualized these similarities as networks
(for BPO, see Fig. 10; for MFO, CCO, and HPO, see
Additional file 1).
In MFO, where we observed the highest overall perfor-
mance of prediction methods, eight of the ten top meth-
ods were in the largest connected component. In addition,
we observed a high connectivity between methods, sug-
gesting that the participating methods are leveraging sim-
ilar sources of data in similar ways. Predictions for BPO
showed a contrasting pattern. In this ontology, the largest
connected component contained only two of the top-ten
methods. The other top methods were contained in com-
ponents made up of other methods produced by the same
lab. This suggests that the approaches that participating
groups have taken generate more diverse predictions for
this ontology and that there are many different paths to
a top-performing biological process prediction method.
Results for HPO were more similar to those for BPO,
while results for cellular component were more similar in
structure to molecular function.
Taken together, these results suggest that ensemble
approaches that aim to include independent sources
of high-quality predictions may benefit from leverag-
ing the data and techniques used by different research
groups and that such approaches that effectively weigh
and integrate disparate methods may demonstrate more
substantial improvements over existing methods in the
process and phenotype ontologies where current predic-
tion approaches share less similarity.
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Fig. 9 Performance evaluation using the maximum F measure, Fmax, on eukaryotic (left) versus prokaryotic (right) benchmark sequences. The
evaluation was carried out on no-knowledge benchmark sequences in the full mode. The coverage of each method is shown within its
performance bar. Confidence intervals (95 %) were determined using bootstrapping with 10,000 iterations on the set of benchmark sequences. For
cases in which a principal investigator participated in multiple teams, the results of only the best-scoring method are presented. Details for all
methods are provided in Additional file 1
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Fig. 10 Similarity network of participating methods for BPO. Similarities are computed as Pearson’s correlation coefficient between methods, with a
0.75 cutoff for illustration purposes. A unique color is assigned to all methods submitted under the same principal investigator. Not evaluated
(organizers’) methods are shown in triangles, while benchmark methods (Naïve and BLAST) are shown in squares. The top-ten methods are
highlighted with enlarged nodes and circled in red. The edge width indicates the strength of similarity. Nodes are labeled with the name of the
methods followed by “-team(model)” if multiple teams/models were submitted
At the time that authors submitted predictions, we also
asked them to select from a list of 30 keywords that best
describe their methodology. We examined these author-
assigned keywords for methods that ranked in the top
ten to determine what approaches were used in currently
high-performing methods (Additional file 1). Sequence
alignment andmachine-learningmethods were in the top-
three terms for all ontologies. For biological process, the
other member of the top three is protein–protein interac-
tions, while for cellular component and molecular func-
tion the third member is sequence properties. The broad
sets of keywords among top-performing methods further
suggest that these methods are diverse in their inputs and
approach.
Case study: ADAM-TS12
To illustrate some of the challenges and accomplishments
of CAFA, we provide an in-depth examination of the
prediction of the functional terms of one protein, human
ADAM-TS12 [16]. ADAMs (a disintegrin and metallo-
proteinase) are a family of secreted metallopeptidases
featuring a pro-domain, a metalloproteinase, a disintegrin,
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a cysteine-rich epidermal growth-factor-like domain, and
a transmembrane domain [17]. The ADAM-TS subfamily
include eight thrombospondin type-1 (TS-1) motifs; it is
believed to play a role in fetal pulmonary development and
may have a role as a tumor suppressor, specifically the neg-
ative regulation of the hepatocyte growth factor receptor
signaling pathway [18].
We did not observe any experimental annotation by
the time submission was closed. Annotations were later
deposited to all three GO ontologies during the growth
phase of CAFA2. Therefore, ADAM-TS12 was considered
a no-knowledge benchmark protein for our assessment in
all GO ontologies. The total number of leaf terms to pre-
dict for biological process was 12; these nodes induced a
directed acyclic annotation graph consisting of 89 nodes.
In Fig. 11 we show the performance of the top-five meth-
ods in predicting the BPO terms that are experimentally
verified to be associated with ADAM-TS12.
As can be seen, most methods correctly discovered
non-leaf nodes with a moderate amount of informa-
tion content. “Glycoprotein Catabolic Process”, “Cellu-
lar Response to Stimulus”, and “Proteolysis” were the
best discovered GO terms by the top-five performers.
The Paccanaro Lab (P) discovered several additional
correct leaf terms. It is interesting to note that only
BLAST successfully predicted “Negative regulation of sig-
nal transduction” whereas the other methods did not. The
reason for this is that we set the threshold for report-
ing a discovery when the confidence score for a term
was equal to or exceeded the method’s Fmax. In this par-
ticular case, the Paccanaro Lab method did predict the
term, but the confidence score was 0.01 below their Fmax
threshold.
This example illustrates both the success and the dif-
ficulty of correctly predicting highly specific terms in
BPO, especially with a protein that is involved in four
distinct cellular processes: in this case, regulation of cel-
lular growth, proteolysis, cellular response to various
cytokines, and cell-matrix adhesion. Additionally, this
example shows that the choices that need to be made
when assessing method performance may cause some
loss of information with respect to the method’s actual
performance. That is, the way we capture a method’s
performance in CAFA may not be exactly the same as
a user may employ. In this case, a user may choose
to include lower confidence scores when running the
Paccanaro Lab method, and include the term “Negative
regulation of signal transduction” in the list of accepted
predictions.
Conclusions
Accurately annotating the function of biological macro-
molecules is difficult, and requires the concerted effort of
experimental scientists, biocurators, and computational
biologists. Though challenging, advances are valuable:
accurate predictions allow biologists to rapidly generate
testable hypotheses about how proteins fit into processes
and pathways. We conducted the second CAFA challenge
to assess the status of the computational function pre-
diction of proteins and to quantify the progress in the
field.
The field has moved forward
Three years ago, in CAFA1, we concluded that the top
methods for function prediction outperform straight-
forward function transfer by homology. In CAFA2, we
observe that the methods for function prediction have
improved compared to those from CAFA1. As part of
the CAFA1 experiment, we stored all predictions from all
methods on 48,298 target proteins from 18 species. We
compared those stored predictions to the newly deposited
predictions from CAFA2 on the overlapping set of bench-
mark proteins and CAFA1 targets. The head-to-head
comparisons among the top-five CAFA1 methods against
the top-five CAFA2 methods reveal that the top CAFA2
methods outperformed all top CAFA1 methods.
Our parallel evaluation using an unchanged BLAST
algorithm with data from 2011 and data from 2014
showed little difference, strongly suggesting that the
improvements observed are due to methodological
advances. The lessons from CAFA1 and annual AFP-SIG
during the ISMB conference, where new developments
are rapidly disseminated, may have contributed to this
outcome [19].
Evaluation metrics
A universal performance assessment in protein function
prediction is far from straightforward. Although various
evaluation metrics have been proposed under the frame-
work of multi-label and structured-output learning, the
evaluation in this subfield also needs to be interpretable
to a broad community of researchers as well as the public.
To address this, we used several metrics in this study as
each provides useful insights and complements the others.
Understanding the strengths and weaknesses of current
metrics and developing better metrics remain important.
One important observation with respect to metrics is
that the protein-centric and term-centric views may give
different perspectives to the same problem. For example,
while in MFO and BPO we generally observe a pos-
itive correlation between the two, in CCO and HPO
these different metrics may lead to entirely different inter-
pretations of an experiment. Regardless of the under-
lying cause, as discussed in “Results and discussion”,
it is clear that some ontological terms are predictable
with high accuracy and can be reliably used in practice
even in these ontologies. In the meantime, more effort
will be needed to understand the problems associated
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Fig. 11 Case study on the human ADAM-TS12 gene. Biological process terms associated with ADAM-TS12 gene in the union of the three databases
by September 2014. The entire functional annotation of ADAM-TS12 consists of 89 terms, 28 of which are shown. Twelve terms, marked in green, are
leaf terms. This directed acyclic graph was treated as ground truth in the CAFA2 assessment. Solid black lines provide direct “is a” or “part of”
relationships between terms, while gray linesmark indirect relationships (that is, some terms were not drawn in this picture). Predicted terms of the
top-five methods and two baseline methods were picked at their optimal Fmax threshold. Over-predicted terms are not shown
with the statistical and computational aspects of method
development.
Well-performingmethods
We observe that participating methods usually special-
ize in one or few categories of protein function predic-
tion, and have been developed with their own application
objectives in mind. Therefore, the performance rankings
of methods often change from one benchmark set to
another. There are complex factors that influence the final
ranking including the selection of the ontology, types of
benchmark sets and evaluation, as well as evaluation met-
rics, as discussed earlier. Most of our assessment results
show that the performances of top-performing methods
are generally comparable to each other. It is worth noting
that performance is usually better in predicting molecular
function than other ontologies.
Beyond simply showing diversity in inputs, our eval-
uation of prediction similarity revealed that many top-
performingmethods are reaching this status by generating
distinct predictions, suggesting that there is additional
room for continued performance improvement. Although
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a small group of methods could be considered as generally
high performing, there is no single method that dominates
over all benchmarks. Taken together, these results high-
light the potential for ensemble learning approaches in
this domain.
We also observed that when provided with a chance to
select a reliable set of predictions, the methods generally
perform better (partial evaluation mode versus full evalu-
ation mode). This outcome is encouraging; it suggests that
method developers can predict where their methods are
particularly accurate and target them to that space.
Our keyword analysis showed that machine-learning
methods are widely used by successful approaches. Pro-
tein interactions were more overrepresented in the best-
performing methods for biological process prediction.
This suggests that predicting membership in pathways
and processes requires information on interacting part-
ners in addition to a protein’s sequence features.
Final notes
Automated functional annotation remains an exciting and
challenging task, central to understanding genomic data,
which are central to biomedical research. Three years
after CAFA1, the top methods from the community have
shown encouraging progress. However, in terms of raw
scores, there is still significant room for improvement in
all ontologies, and particularly in BPO, CCO, and HPO.
There is also a need to develop an experiment-driven,
as opposed to curation-driven, component of the evalu-
ation to address limitations for term-centric evaluation.
In the future CAFA experiments, we will continue to
monitor the performance over time and invite a broad
range of computational biologists, computer scientists,
statisticians, and others to address these engaging prob-
lems of concept annotation for biological macromolecules
through CAFA.
CAFA2 significantly expanded the number of protein
targets, the number of biomedical ontologies used for
annotation, the number of analysis scenarios, as well as
the metrics used for evaluation. The results of the CAFA2
experiment detail the state of the art in protein function
prediction, can guide the development of new concept
annotation methods, and help molecular biologists assess
the relative reliability of predictions. Understanding the
function of biological macromolecules brings us closer to
understanding life at the molecular level and improving
human health.
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